当前位置: X-MOL 学术Inorg. Chem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Radiochemistry and Complex Formation of the Cyclen-Derived Chelator DOTI-Me with Mn2+, Cu2+, Zn2+, Ga3+, In3+, Tb3+, and Lu3+
Inorganic Chemistry ( IF 4.3 ) Pub Date : 2024-10-01 , DOI: 10.1021/acs.inorgchem.4c03571
Ina Hierlmeier, Nadia Marino, Moritz-Valentin Schreck, Lukas Schneider, Stephan Maus, Kendall Barrett, Margarita Kretowicz, Jonathan W. Engle, Giovanni Pierri, Samer Ezziddin, Mark D. Bartholomä

In this work, we describe the complex formation and radiochemistry of the cyclen-based chelator DOTI-Me bearing four methylimidazole arms. Radiolabeling properties were evaluated for 52gMn, 64Cu, 68Ga, 111In, 161Tb, and 177Lu, and DOTI-Me showed distinct differences to the structurally related H4DOTA. While radiochemical conversions (RCCs) for 52gMn and 111In were comparable to those of H4DOTA, DOTI-Me was not suited for 68Ga. Conversely, quantitative RCCs were achieved for 64Cu at ambient temperature, while elevated temperatures were required for complexation with H4DOTA. For 161Tb and 177Lu, good but not quantitative RCCs were obtained with DOTI-Me. With the exemption of 68Ga3+, radiolabeled complexes showed high stability in ligand challenge experiments and in human serum. X-ray analysis of the nonradioactive complexes revealed the formation of 8-coordinate Mn2+ and In3+ DOTI-Me complexes. Cu2+ adopted a unique distorted square-pyramidal 2 + 3 with the neutral DOTI-Me ligand and a Jahn–Teller distorted 4 + 2 coordination geometry for the diprotonated H2DOTI-Me2+ cation, respectively. For Zn2+, the complex with HDOTI-Me+ showed a distorted 4 + 3 pentagonal bipyramidal geometry. Summarizing, the ligand DOTI-Me may be an interesting alternative to H4DOTA for 52gMn, 64Cu, 111In, 161Tb, and 177Lu, covering diagnostic as well as therapeutic radionuclides. Further studies of targeted radiopharmaceuticals based on the DOTI-Me scaffold in combination with the set of radiometals presented herein are thus warranted.

中文翻译:


Cyclen 衍生的螯合剂 DOTI-Me 与 Mn2+、Cu2+、Zn2+、Ga3+、In3+、Tb3+ 和 Lu3+ 的放射化学和复合物形成



在这项工作中,我们描述了带有四个甲基咪唑臂的基于环素的螯合剂 DOTI-Me 的复合物形成和放射化学。评估了 52gMn、64Cu、68Ga、111In、161Tb 和 177Lu 的放射性标记特性,DOTI-Me 与结构相关的 H4DOTA 显示出明显差异。虽然 52gMn 和 111In 的放射化学转化率 (RCC) 与 H4DOTA 相当,但 DOTI-Me 不适用于 68Ga。相反,在环境温度下,64Cu 的定量 RCC 可实现,而与 H4DOTA 络合需要高温。对于 161Tb 和 177Lu,使用 DOTI-Me 获得良好但不定量的 RCC。在豁免 68Ga3+ 的情况下,放射性标记的复合物在配体攻击实验和人血清中表现出高稳定性。非放射性配合物的 X 射线分析揭示了 8 配位 Mn2+ 和 In3+ DOTI-Me 配合物的形成。Cu2+ 分别采用具有中性 DOTI-Me 配体的独特扭曲方形金字塔 2 + 3 和二质子化 H2DOTI-Me2+ 阳离子的 Jahn-Teller 扭曲 4 + 2 配位几何。对于 Zn2+,与 HDOTI-Me+ 的复合物显示出扭曲的 4 + 3 五边形双锥几何形状。总而言之,配体 DOTI-Me 可能是 H4DOTA 的有趣替代品,适用于 52gMn、64Cu、111In、161Tb 和 177Lu,涵盖诊断和治疗放射性核素。 因此,有必要进一步研究基于 DOTI-Me 支架的靶向放射性药物与本文提出的一组放射性金属相结合。
更新日期:2024-10-01
down
wechat
bug